Inaktiver Wert

Andere Sprachen Cosmo Pharmaceuticals S.p.A Swiss Exchange

Aktien

IT0004167463

Schlusskurs Swiss Exchange Andere Börsenplätze
- ^CHF	-

03.06.	Morning Briefing - Markt Schweiz	AW
29.04.	Cosmo darf definitive Jahresrechnung 2023 bis Ende Mai veröffentlichen	AW

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Cosmo Pharmaceuticals N : EGM – 5 July 2024 – Written Proxy	06.06.
Cosmo Pharmaceuticals N : EGM – 5 July 2024 – Proposed Amendments to the Renumeration Policy	06.06.
Cosmo Pharmaceuticals N : EGM – 5 July 2024 – Notification of number of shares as of 6 June 2024	06.06.
Cosmo Pharmaceuticals N : EGM – 5 July 2024 – Explanatory Notes	06.06.
Cosmo Pharmaceuticals N : EGM – 5 July 2024 – Convening Notice	06.06.
Cosmo Pharmaceuticals N : Written proxy – EGM 5 July 2024	06.06.
Cosmo Pharmaceuticals N : Proposed Amendments to the Remuneration Policy – EGM 5 July 2024	06.06.
Cosmo Pharmaceuticals N : Notification of number of shares 6 June 2024 – EGM 5 July 2024	06.06.
Cosmo Pharmaceuticals N : Explanatory notes – EGM 5 July 2024	06.06.
Cosmo Pharmaceuticals N : Convening notice – EGM 5 July 2024	06.06.
Cosmo Pharmaceuticals Swings to Loss in FY23; Revenue Down	03.06.
Cosmo to Bring Real-Time AI into Intelligent Medical Devices with NVIDIA IGX	03.06.
Cosmo Reports Excellent Final Full Year 2023 Financial Results - Increases Operating Profit Guidance for 2024 - Dividend of 2.00 per Share Will Be Proposed at EGM on 5 July 2024	01.06.
Cosmo Pharmaceuticals N : reports excellent final Full Year 2023 financial results – Increases operating profit guidance for 2024 – Dividend of € 2.00 per share will be proposed at EGM on 5 July 2024	31.05.
Cosmo Pharmaceuticals' Shareholders Approve All Agenda Items at Annual General Meeting	24.05.
Cosmo Pharmaceuticals N : ’ Shareholders approve all Agenda Items at Annual General Meeting	24.05.
Cosmo Pharmaceuticals N : Niall Donnelly CV	09.05.
Cosmo Pharmaceuticals N : Convening notice	09.05.
Cosmo Pharmaceuticals N : Written Proxy	09.05.
Cosmo Pharmaceuticals N : Explanatory notes	09.05.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Cosmo Pharmaceuticals S.p.A Swiss Exchange

Aktien

IT0004167463

Andere Sprachen

Filter